Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies
Adaptam Therapeutics has raised $3.5M in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2025.
Adaptam Therapeutics's investors include Criteria Bio Ventures.
Adaptam Therapeutics is headquartered in Donostia-san Sebastián, Spain.
Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies
Adaptam Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adaptam Therapeutics — Funding & Investors." VCBacked, October 27, 2025, https://www.vcbacked.co/company/adaptam-therapeutics. Accessed August 1, 2026.
VCBacked. (2025). Adaptam Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/adaptam-therapeutics
{{cite web |title=Adaptam Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/adaptam-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated